Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02510040 · ClinicalTrials.gov registry record

A Prospective Observational Study of Adult Strabismus

A clinical trial of Convergence Insufficiency and Divergence Insufficiency, sponsored by Jaeb Center for Health Research.

Completed
Registry status
217
Enrollment target
1
Study location

NCT02510040: Completed study of Convergence Insufficiency and Divergence Insufficiency, sponsored by Jaeb Center for Health Research.

NCT02510040 is a study of Convergence Insufficiency and Divergence Insufficiency that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 217 participants, above the 90-participant average among 6 other Convergence Insufficiency trials with a reported enrollment target (141% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02510040, a study of Convergence Insufficiency and Divergence Insufficiency, has completed, sponsored by Jaeb Center for Health Research.

COMPLETED
Registry status
217 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to describe clinical characteristics, treatments, and one-year outcomes of adults with convergence insufficiency, divergence insufficiency, or small angle hypertropia.

Primary Outcome

In the convergence insufficiency group, the primary outcome will be symptom success at the 10-week and 12-month visit, defined as improvement of CI Symptom Survey (CISS) score of at least 9 points and an outcome score of \<21 points. In the divergence insufficiency group, the primary outcome will be symptom success at the 10-week and 12-month visit, defined as diplopia "rarely" or "never" in primary position at distance on the diplopia questionnaire. In the small-angle hypertropia group, the pri

Conditions Studied

Convergence Insufficiency Divergence Insufficiency Hypertropia

Interventions

  • DEVICE Prism
  • OTHER Orthoptic Exercises
  • PROCEDURE Eye Muscle Surgery
  • PROCEDURE Botox Injection

Study Locations (1)

Virginia

  • Earl R. Crouch, III - Norfolk

Trial Details

FieldValue
Enrollment Target 217 participants
Start Date 2015-08-17
Est. Completion 2019-01-31
Jaeb Center for Health Research

119 total trials

What the finished NCT02510040 record still lists

NCT02510040 is an observational study that tracks outcomes without assigning an intervention. The registered 217 participants enrollment target is mid-sized for trials with a published cap, above the 90-participant average among 6 other Convergence Insufficiency trials with a reported enrollment target (141% higher).

The record links to 3 conditions, with Convergence Insufficiency appearing as the primary indexed condition, and to 4 interventions - of which Prism is the first listed.

NCT02510040 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT02510040 about?

NCT02510040 is a clinical study titled "A Prospective Observational Study of Adult Strabismus". The purpose of this study is to describe clinical characteristics, treatments, and one-year outcomes of adults with convergence insufficiency, divergence insufficiency, or small angle hypertropia.

What is the current status of trial NCT02510040?

This trial is currently completed. The enrollment target is 217 participants. The study started on 2015-08-17. Estimated completion is 2019-01-31.

What conditions does trial NCT02510040 study?

This clinical trial studies the following conditions: Convergence Insufficiency, Divergence Insufficiency, Hypertropia.

What interventions are being tested in trial NCT02510040?

The interventions under investigation include: Prism (DEVICE), Orthoptic Exercises (OTHER), Eye Muscle Surgery (PROCEDURE), Botox Injection (PROCEDURE).

Who is sponsoring clinical trial NCT02510040?

This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02510040 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Convergence Insufficiency

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05079282 · 217 participants · Phase 1

    Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

  • NCT05470439 · 217 participants · NA

    My Interprofessional Care Team for Adherence and Research Engagement Disparities

  • NCT05981703 · 217 participants · Phase 1

    A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

  • NCT06342258 · 217 participants · Phase 1

    COES: Curing Order Effects on Sealants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT02510040, the US trial registry maintained by the National Library of Medicine. NCT02510040 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.